Advances in the diagnosis and therapy of mycobacterial disease

Cutis

Volumn 79, Issue 1, 2007, Pages 17-19

  Elston, Dirk M ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

BACTERIAL SKIN DISEASE; CLASSIFICATION; EDITORIAL; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM; NUCLEIC ACID HYBRIDIZATION; SKIN TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; DNA, BACTERIAL; HUMANS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NUCLEIC ACID HYBRIDIZATION; SKIN DISEASES, BACTERIAL; TUBERCULOSIS, CUTANEOUS;

EID: 33846856214     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (29)

1. Johnson RP, Xia Y, Cho S, et al. Mycobacterium marinum infection: a case report and review of the literature. Cutis. 2007;79:33-36.
2. Moiton MP, Richez C, Dumoulin C, et al. Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections. Clin Microbiol Infect. 2006;12:1151-1153.
3. Stas P, D'Hoore A, Van Assche G, et al. Miliary tuberculosis following infliximab therapy for Crohn disease: a case report and review of the literature. Acta Gastroenterol Belg. 2006;69:217-220.
4. Sichletidis L, Settas L, Spyratos D, et al. Tuberculosis in patients receiving anti-TNF agents despite chemoprophy-laxis. Int J Tuberc Lung Dis. 2006;10:1127-1132.
5. Okubo H, Iwamoto M, Yoshio T, et al. Rapidly aggravated Mycobacterium avium infection in a patient with rheumatoid arthritis treated with infliximab. Mod Rheumatol. 2005;15:62-64.
6. De Backer AI, Mortele KJ, De Keulenaer BL, et al. Tuberculosis: epidemiology, manifestations, and the value of medical imaging in diagnosis. JBR-BTR, 2006;89: 243-250.
7. Courtenay O, Reilly LA, Sweeney FP, et al. Is Mycobacterium bovis in the environment important for the persistence of bovine tuberculosis? Biol Lett. 2006;2:460-462.
8. Harris NB, Payeur J, Bravo D, et al. Recovery of Mycobacterium bovis from soft fresh cheese originating from Mexico. Appl Environ Microbiol [serial online]. December 1, 2006.
9. Tsai HC, Lee SS, Wann SR, et al. Mycobacterium marinum tenosynovitis: three case reports and review of the literature. Jpn J Infect Dis. 2006;59:337-340.
10. Uslan DZ, Kowalski TJ, Wengenack NL, et al. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006;142:1287-1292.
11. Redbord KP, Shearer DA, Gloster H, et al. Atypical Mycobacterium furunculosis occurring after pedicures. J Am Acad Dermatol. 2006;54:520-524.
12. Song JY, Sohn JW, Jeong HW, et al. An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus. BMC Infect Dis. 2006;6:6.
13. Giannella M, Pistella E, Perciaccante A, et al. Soft tissue infection caused by Mycobacterium chelonae following a liposculpture and lipofilling procedure. Ann Ital Med Int. 2005;20:245-247.
14. Coloma JN, Navarrete-Franco G, Iribe P, et al. Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases. Int J Lepr Other Mycobact Dis. 2005;73:5-12.
15. S Breza T Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical Mycobacterium infections. J Cutan Pathol. 2006;33:512-515.
16. Gomez MP, Herrera-Leon L, Jimenez MS, et al. Comparison of GenoType((R)) MTBC with RFLP-PCR and multiplex PCR to identify Mycobactrium tuberculosis complex species. Eur J Clin Microbiol Infect Dis [serial online]. December 5, 2006.
17. Kobashi Y, Obase Y, Fukuda M, et al. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis. 2006;43:1540-1546.
18. Martinez AN, Britto CF, Nery JA, et al. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy. J Clin Microbiol. 2006;44:3154-3159.
19. Kamal R, Dayal R, Katoch VM, et al. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy. Lepr Rev. 2006;77:141-146.
20. Tsiouris SJ, Coetzee D, Toro PL, et al. Sensitivity analysis and potential uses of a novel gamma Interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006;44:2844-2850.
21. Ostrowski SR, Ravn P, Hoyer-Hansen G, et al. Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: still looking for a marker of treatment efficacy. Scand J Infect Dis. 2006;38:1028-1032.
22. Lindeboom JA, Kuijper EJ, Prins JM, et al. Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis. 2006;43:1547-1551.
23. Akoglu G, Karaduman A, Boztepe G, et al. A case of lupus vulgaris successfully treated with antituberculous therapy despite negative PCR and culture. Dermatology. 2005;211:290-292.
24. Petrini B. Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections. Eur J Clin Microbiol Infect Dis [serial online]. September 19, 2006.
25. Cummins DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol. 2005;44:518-520.
26. Rajesh G, Ip WY, Chow SP, et al. Treating deep-seated Mycobacterium marinum infection in the hand: a report of three cases. Hand Surg. 2006; 11:83-88.
27. Wiegell SR, Kongshoj B, Wulf HC. Mycobacterium marinum infection cured by photodynamic therapy. Arch Dermatol. 2006;142:1241-1242.
28. Shandil RK, Jayaram R, Kaur P, et al. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrob Agents Chemother [serial online]. December 4, 2006.
29. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS. 2006;114:319-328.